Inventor · disambiguated record
Thomas B. Borchardt
Also filed as: BORCHARDT THOMAS · BORCHARDT THOMAS B
25 granted patents·18 pending applications·249 citations·filing 2000–2025
96Inventor score
Top patents by PatentIndex Score
43 records- 0198US11512092B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Nov 29, 2022·21 cites·22 claims
- 0298US11198697B1Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Dec 14, 2021·29 cites·30 claims
- 0398US11186584B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Nov 30, 2021·28 cites·23 claims
- 0498US10981923B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2020·Granted Apr 20, 2021·32 cites·30 claims
- 0598US10017517B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Jul 10, 2018·41 cites·30 claims
- 0697US11680069B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Jun 20, 2023·6 cites·30 claims
- 0797US11661425B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted May 30, 2023·9 cites·30 claims
- 0894US7820812B2Methods of manufacturing crystalline forms of rapamycin analogsABBOTT LAB·Filed 2007·Granted Oct 26, 2010·17 cites·21 claims
- 0990US7960564B2Crystalline chemotherapeuticABBOTT LAB·Filed 2008·Granted Jun 14, 2011·8 cites·1 claims
- 1090US2024376115A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2024·Application pending·0 cites
- 1189US2024317770A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2024·Application pending·0 cites
- 1286US8513243B2ABT-263 crystalline formsZHANG GEOFF G Z·Filed 2011·Granted Aug 20, 2013·4 cites·2 claims
- 1386US8034926B2Methods of manufacturing crystalline forms of rapamycin analogsABBOTT LAB·Filed 2010·Granted Oct 11, 2011·4 cites·25 claims
- 1486US7812032B2Crystalline forms of rapamycin analogsABBOTT LAB·Filed 2007·Granted Oct 12, 2010·8 cites·18 claims
- 1586US2023374027A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2023·Application pending·0 cites
- 1685US7378414B2Anti-infective agentsABBOTT LAB·Filed 2004·Granted May 27, 2008·17 cites·30 claims
- 1782US8362014B2ABT-263 crystalline formsABBVIE INC·Filed 2010·Granted Jan 29, 2013·2 cites·2 claims
- 1882US2020291040A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2019·Application pending·0 cites
- 1981US8030326B2Crystalline forms of rapamycin analogsABBOTT LAB·Filed 2010·Granted Oct 4, 2011·5 cites·15 claims
- 2081US7772404B2Crystalline form 2 of the chemotherapeutic N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)ureaABBOTT LAB·Filed 2008·Granted Aug 10, 2010·8 cites·1 claims
- 2179US2025163071A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3,-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2025·Application pending·0 cites
- 2277US2021363149A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2021·Application pending·0 cites
- 2376US8771835B2Substantially biodegradable and compostable high-barrier packaging material and methods for productionIYENGAR GOPAL·Filed 2008·Granted Jul 8, 2014·5 cites·8 claims
- 2474US7947843B2Crystalline chemotherapeuticABBOTT LAB·Filed 2008·Granted May 24, 2011·3 cites·1 claims
- 2571US8362013B2Salt of ABT-263 and solid-state forms thereofABBVIE INC·Filed 2010·Granted Jan 29, 2013·2 cites·10 claims
- 2666US2022281882A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2022·Application pending·0 cites
- 2759US7994208B2Crystalline chemotherapeuticABBOTT LAB·Filed 2008·Granted Aug 9, 2011·0 cites·5 claims
- 2855US7538105B2Anti-infective agentsABBOTT LAB·Filed 2008·Granted May 26, 2009·0 cites·19 claims
- 2952US8759538B1Crystalline chemotherapeuticABBVIE INC·Filed 2013·Granted Jun 24, 2014·0 cites·2 claims
- 3051US9260411B2Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrileMCDERMOTT TODD S·Filed 2007·Granted Feb 16, 2016·0 cites·8 claims
- 3151US2007087212A1Multi-layer, high barrier packaging materialsSTORA ENSO NORTH AMERICA CORP·Filed 2006·Application pending·0 cites
- 3250US12159769B2Device for forming physical plasma on a surface of an objectHOCHSCHULE FUER ANGEWANDTE WSS UND KUNST HILDESHEIM/HOLZMINDEN/GOETTINGEN·Filed 2022·Granted Dec 3, 2024·0 cites·16 claims
- 3350US2012028908A1Methods of Manufacturing Crystalline Forms of Rapamycin AnalogsVISWANATH SHEKHAR·Filed 2011·Application pending·0 cites
- 3448US2005261261A1Eplerenone drug substance having high phase purityPHARMACIA CORP·Filed 2005·Application pending·0 cites
- 3546US8486988B2Crystalline chemotherapeuticBORCHARDT THOMAS B·Filed 2011·Granted Jul 16, 2013·0 cites·1 claims
- 3645US2009149431A1Eplerenone Drug Substance Having High Phase PurityBARTON KATHLEEN P·Filed 2009·Application pending·0 cites
- 3743US2005159594A1Eplerenone crystal form exhibiting enhanced dissolution ratePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3842US2003083493A1Eplerenone drug substance having high phase purityFiled 2002·Application pending·0 cites
- 3941US2005267302A1Eplerenone crystalline form exhibiting enhanced dissolution rateSEARLE & CO·Filed 2003·Application pending·0 cites
- 4040US2016152600A1Synthesis of (2s,5r)-5-ethynyl-1-pyrrolidine-2-carbonitrileABBVIE INC·Filed 2016·Application pending·0 cites
- 4138US2003232871A1Crystalline parecoxib sodiumFiled 2003·Application pending·0 cites
- 4234US2002045746A1Eplerenone crystalline formFiled 2000·Application pending·0 cites
- 4334US2002038021A1Eplerenone crystalline form exhibiting enhanced dissolution rateFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas B. Borchardt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →